Orgenesis Inc.
OTC: ORGS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Vered Caplan
- Employees
- 146
- Headquarters
- Germantown, United States
- IPO year
- 2012
- Market cap
- $2.1M
- Website
- https://www.orgenesis.com
Loading ORGS…
Loading profile data…Frequently asked questions about ORGS
What does Orgenesis Inc. (ORGS) do?
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative...
Where does ORGS trade?
Orgenesis Inc. (ORGS) trades on the Other OTC.
What sector is ORGS in?
Orgenesis Inc. (ORGS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Orgenesis Inc.?
Vered Caplan is the chief executive officer of Orgenesis Inc. (ORGS).
Where is Orgenesis Inc. headquartered?
Orgenesis Inc. is headquartered in United States.
Does ORGS pay a dividend?
Orgenesis Inc. (ORGS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORGS go public?
Orgenesis Inc. (ORGS) completed its initial public offering in 2012.